IART NASDAQ
Integra LifeSciences Holdings Corporation
1W: -21.3%
1M: -24.6%
3M: -30.2%
YTD: +5.6%
1Y: -13.9%
3Y: -66.5%
5Y: -82.4%
$12.68
-3.41 (-21.19%)
Weekly Expected Move ±11.9%
$10
$11
$13
$14
$16
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2023-12-13
Earliest Filing
2023-12-13
Latest Filing
target: 1
partner: 1
licensee: 1
Counterparties (Filed by IART)
3 relationshipsCompanies named in IART's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Ethicon, Inc. | — | target | Seller of Acclarent, Inc. shares and assets | 2023-12-13 | View |
| Johnson & Johnson | JNJ | partner | Parent company of Seller (Ethicon, Inc.) | 2023-12-13 | View |
| Biosense Webster (Israel) Ltd. | — | licensee | Licensor of intellectual property to Acclarent | 2023-12-13 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-02 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-09-08 | Regulation FD; Exhibits | View | |
| 2026-07-29 | Earnings Release; Exhibits | View | |
| 2026-05-08 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-05 | Earnings Release; Exhibits | View | |
| 2026-05-05 | Officer/Director Change; Exhibits | View | |
| 2026-04-15 | Material Agreement | Agreement | View |
| 2026-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-12 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-10-30 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-31 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-09 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-05-13 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-25 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-06 | Other Events | View | |
| 2024-12-17 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-11-04 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2024-11-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-07-29 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR